通过蛋白质组分析开发生物标志物面板和药物,用于自身免疫性脑膜炎和后硬化炎

Xueru Li1, Jinying An1, Lingzi Wu2

  • 1Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China.

iScience
|December 17, 2024
PubMed
概括

这项研究确定了自身免疫性眼球疾病的新型血生物标志物,如贝赫特卵膜炎和Vogt-Koyanagi-Harada综合征. 这些生物标志物提高了诊断的准确性,并为免疫相关的视力丧失提供了潜在的治疗点.